Gynecologists

• Gynecology
  Dr. Joe Buscema is a gynecologic oncologist who specializes in obstetrics and gynecology. He graduated from Johns Hopkins University School of Medicine. Dr. Buscema completed his residency and fellowship in gynecologic oncology at Johns Hopkins University. He has authored numerous articles on gynecologic cancer which have been published in Gynecologic Oncology, Obstetrics & Gynecology, the American Journal of Obstetrics & Gynecology Cancer, The Annual Review of Medicine, and The American Journal of Clinical Pathology. See full bio here.
• Obstetrics
  Dr. Audrey Garrett is medical director of gynecologic oncology at Willamette Valley Cancer Institute. She board-certified in gynecologic oncology, obstetrics and gynecology, palliative care medicine and received her medical degree and MPH from Columbia University. Garrett completed a fellowship and residency at Brigham and Women’s hospital, Harvard University. She is also a clinical assistant professor of obstetrics and gynecology at Oregon Health & Science University in Portland. See full bio here.

Internists

• Internal Medicine
  Dr. Leslie Busby is board-certified in hematology and medical oncology. He is medical director at Rocky Mountain Cancer Centers. Busby received his medical degree from The University of Nevada, School of Medicine, Reno, NV and completed his residency in internal medicine at the University of Missouri-Kansas City, Kansas City, MO. See full bio here.
• Bladder Cancer
• Ovarian Cancer
• Cervical Cancer
• Colon Cancer
• Prostate Cancer
• Cancer Care
  The US Oncology Network believes local cancer care is better care. We empower the delivery of advanced integrated cancer care through our network of independent physicians who share expertise and resources to provide quality, value-based care close to home.
• Lung Cancer
  As lung cancer treatment becomes increasingly personalized to include targeted therapies into earlier stages of disease, The US Oncology Network is proud to bring together a diverse set of organizations and stakeholders working across the spectrum of non-small cell lung cancer (NSCLC) therapy, drug development and care to improve the lives of patients. A unique, collaborative real-world research consortium, MYLUNG will study up to 12,000  NSCLC patients in the community setting over five years.

Endocrinologist

• Thyroid
• Thyroid Cancer

Radiologist

• Radiology
  Dr. Todd Doyle is a board-certified radiation oncologist practicing at New York Oncology and Hematology (NYOH). He received his medial degree from Albany Medical College and completed residencies in radiation oncology at the Mallinckrodt Institute of Radiology and Hospital of the University of Pennsylvania. See full bio here.
• Chemotherapy
  The support of the technology and IT services we receive as part of The Network is simply priceless. The Network’s ability to buy chemotherapy medication at best possible price results in improved financial efficiency, and the benefits program and power in numbers allows us to attract and keep fabulous nurses.
• Radiation Oncology
  In the JV model, practices and McKesson each own a share of a radiation oncology asset and participate in the financial performance of that asset. Physicians maintain their independence, but get the support of a management company that has deep expertise in radiation oncology management. Join Our Network